Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept.

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Omnicell (OMCL – Research Report) today. The company’s shares closed yesterday at $33.34. Easily identify stocks' risks and ...

Omnicell (OMCL) announced that Nchacha Etta will be stepping down from his role as executive VP and CFO, effective September 15 or until a successor is named. Etta will continue to serve as CFO ...

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning. Omnicell ( NASDAQ:OMCL ) Full ...

FORT WORTH, Texas, March 12, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...